sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
21-Apr-2014 07:19
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 676-700 out of 890.

<< < 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 > >>

Public Release: 17-Sep-2012
Diabetes Care
Risk of developing diabetes higher in neighborhoods that aren't walk-friendly: Study
Whether your neighborhood is conducive to walking could determine your risk for developing diabetes, according to a new study by researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences.

Contact: Kate Taylor
TaylorKa@smh.ca
416-864-6094
St. Michael's Hospital

Public Release: 17-Sep-2012
EMBO Molecular Medicine
Scientists reveal how natural antibiotic kills tuberculosis bacterium
A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works. This promising drug candidate is active against many of the drug-resistant types of the tuberculosis bacterium that no longer respond to treatment with the front-line drug isoniazid.

Contact: Barry Whyte
barry.whyte@embo.org
49-622-188-91108
European Molecular Biology Organization

Public Release: 13-Sep-2012
UCLA's Aydogan Ozcan lauded as one of world's most brilliant innovators by Popular Science
Popular Science magazine has named Aydogan Ozcan, an associate professor of electrical engineering and bioengineering at UCLA, one of the world's "Brilliant 10" scientists in its October 2012 issue.

Contact: Matthew Chin
mchin@support.ucla.edu
310-206-0680
University of California - Los Angeles

Public Release: 13-Sep-2012
Journal of Biological Chemistry
Mutation breaks HIV's resistance to drugs
The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.

Contact: Tim Wall
walltj@missouri.edu
573-882-3346
University of Missouri-Columbia

Public Release: 13-Sep-2012
Journal of American Chemical Society
IU chemist develops new synthesis of most useful, yet expensive, antimalarial drug
In 2010 malaria caused an estimated 665,000 deaths, mostly among African children. Now, chemists at Indiana University have developed a new synthesis for the world's most useful antimalarial drug, artemisinin, giving hope that fully synthetic artemisinin might help reduce the cost of the live-saving drug in the future.
Indiana University

Contact: Steve Chaplin
stjchap@iu.edu
812-856-1896
Indiana University

Public Release: 13-Sep-2012
PLOS Pathogens
Scripps Research scientists reveal how deadly virus silences immune system
Scientists at The Scripps Research Institute have determined the structure of a critical protein from the Marburg virus, a close cousin of Ebola virus. These viruses cause similar diseases and are some of the deadliest pathogens on the planet, each killing up to 90 percent of those infected.
Burroughs Wellcome Fund, Skaggs Institute for Chemical Biology at The Scripps Research Institute

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 13-Sep-2012
'Saving brains' in developing countries: $11.8 million for innovative ideas worldwide
With the goal of helping children in resource-poor countries meet their full intellectual potential, 11 projects in Asia, Africa and South America will receive in all some $11.8 million from the Government of Canada via Grand Challenges Canada to test innovations to address four impediments to cognitive development -- inadequate nurturing, nutrition deficiency, premature birth, and infection.
Grand Challenges Canada

Contact: Terry Collins
tc@tca.tc
416-538-8712
Sandra Rotman Centre for Global Health

Public Release: 11-Sep-2012
Proceedings of the National Academy of Sciences
Genetic make-up of children explains how they fight malaria infection
Researchers from Sainte-Justine University Hospital Center and University of Montreal have identified several novel genes that make some children more efficient than others in the way their immune system responds to malaria infection.

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal

Public Release: 11-Sep-2012
Lancet
Dengue Vaccine Initiative welcomes latest progress in vaccine development
Today, the Dengue Vaccine Initiative welcomed new clinical trial results that reveal progress in developing the first-ever dengue vaccine. In a publication in the Lancet, pharmaceutical company Sanofi Pasteur reported results from the first study conducted to evaluate the efficacy of any dengue vaccine candidate against clinical dengue disease in a population naturally exposed to dengue.

Contact: Johanna Harvey
johanna.harvey@sabin.org
202-621-1691
Sabin Vaccine Institute

Public Release: 11-Sep-2012
Journal of Antimicrobial Chemotherapy
Diet could combat adverse side-effects of quinine
Scientists at the University of Nottingham say adverse side-effects caused by the anti-parasitic drug quinine in the treatment of malaria could be controlled by what we eat.

Contact: Lindsay Brooke
lindsay.brooke@nottingham.ac.uk
44-011-595-15751
University of Nottingham

Public Release: 11-Sep-2012
European Heart Journal
Results from world's first registry of pregnancy and heart disease
Results from the world's first registry of pregnancy and heart disease have shown that most women with heart disease can go through pregnancy and delivery safely, so long as they are adequately evaluated, counseled and receive high quality care. However, the research published in the European Heart Journal shows there are important differences: Mothers and babies in developing countries are more likely to die than those in developed countries, and women with cardiomyopathy also have worse outcomes.
European Society of Cardiology

Contact: Emma Mason
wordmason@mac.com
European Society of Cardiology

Public Release: 11-Sep-2012
PLOS Medicine
Blood transfusion services in Africa should suit local contact -- funders take note
"Flexibility and pragmatism are necessary to reduce the unacceptably high rates of unnecessary deaths in Africa because blood for transfusion is lacking," according to a group of 20 international authors from high-, middle- and low-income countries writing in this week's PLOS Medicine.

Contact: Sumrina Yousufzai
syousufzai@plos.org
415-568-3164
PLOS

Public Release: 10-Sep-2012
Journal of Clinical Investigation
'Humanized' mice developed at OHSU enable malaria research breakthrough at Seattle BioMed
A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.
Bill and Melinda Gates Foundation, US Department of Defense

Contact: Tamara Hargens-Bradley
hargenst@ohsu.edu
503-494-8231
Oregon Health & Science University

Public Release: 10-Sep-2012
Lancet
India's patent laws under pressure: The Lancet special report
In a special report published in the Lancet today, researchers from Queen Mary, University of London argue that pending cases against India's patent laws threaten public health and misinterpret international intellectual property agreements.

Contact: Emma Mason
e.mason@qmul.ac.uk
Queen Mary, University of London

Public Release: 10-Sep-2012
Funding for neglected global diseases research at UBC exceeds $20 million
Researchers with the Neglected Global Diseases Initiative at the University of British Columbia have attracted more than $20 million in funding to find ways to eliminate diseases and conditions that kill millions of people in developing countries worldwide.
Canadian Institutes of Health Research, Bill and Melinda Gates Foundation, Canadian International Development Agency

Contact: Kishor Wasan
kishor.wasan@ubc.ca
604-454-4864
University of British Columbia

Public Release: 10-Sep-2012
Nature
RV144 vaccine efficacy increased against certain HIV viruses
Scientists used genetic sequencing to discover new evidence that the first vaccine shown to prevent HIV infection in people also affected the viruses in those who did become infected. Viruses with two genetic "footprints" were associated with greater vaccine efficacy. The results were published today in the online edition of the journal Nature.
NIH/National Institute of Allergy and Infectious Diseases, Henry M. Jackson Foundation, US Deptartment of Defense

Contact: Lisa Reilly
lreilly@hivresearch.org
301-500-3633
US Army Medical Research Institute of Infectious Diseases

Public Release: 9-Sep-2012
Nature Medicine
OHSU research helps explain why an AIDS vaccine has been so difficult to develop
New research by Oregon Health & Science University scientists explains a decades-old mystery as to why slightly weakened versions of the monkey AIDS virus were able to prevent subsequent infection with the fully virulent strain, but were too risky for human use, and why severely compromised or completely inactivated versions of the virus were not effective at all.
National Institutes of Health

Contact: Jim Newman
newmanj@ohsu.edu
503-494-8231
Oregon Health & Science University

Public Release: 7-Sep-2012
Zoonoses and Public Health
Precautions for tick-borne disease extend 'beyond Lyme'
This year's mild winter and early spring were a bonanza for tick populations in the eastern United States. Reports of tick-borne disease rose fast.
National Science Foundation

Contact: Cheryl Dybas
cdybas@nsf.gov
703-292-7734
National Science Foundation

Public Release: 6-Sep-2012
Advocacy toolkit launched to halt the 'runaway train' of cancer in Africa
In order to try to create a better recognition of the rising burden of cancer in Africa where it is most needed –in Africa– a 'toolkit' for local cancer advocates will be launched Saturday, Sept. 15 at a conference.

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Public Release: 6-Sep-2012
14th International Symposium on Microbial Ecology
Journal of Human Nutrition and Dietetics
New research: Soluble corn fiber plays important role in gut health and calcium absorption
Two new research studies supported by Tate & Lyle, the global provider of specialty food ingredients and solutions, provide further evidence that certain higher-fiber diets can be well-tolerated, and that fiber may play an important role in supporting a healthy gut as well as promoting calcium absorption.
Tate & Lyle

Contact: Allison Parker
aparker@foodminds.com
585-260-8681
FoodMinds LLC

Public Release: 5-Sep-2012
Students create low-cost biosensor to detect contaminated water in developing nations
Diarrheal disease is the second leading cause of death in children under five years old -- killing as many as 1.5 million children worldwide every year. These startling statistics from the World Health Organization point to the reason why a team of nine Arizona State University students is participating in the International Genetically Engineered Machine competition -- a global event that challenges students to design and build simple biological systems made from standard, interchangeable parts.

Contact: Sandra Leander
sandra.leander@asu.edu
480-965-9865
Arizona State University

Public Release: 5-Sep-2012
PLOS ONE
The best strategy to defeat HIV in South Africa
Researchers at UCLA suggest a strategy being proposed by the World Health Organization to combat HIV in South Africa is badly flawed.

Contact: Mark Wheeler
mwheeler@mednet.ucla.edu
310-794-2265
University of California - Los Angeles

Public Release: 5-Sep-2012
New England Journal of Medicine
Call for a new approach to fighting tuberculosis
Each year, nearly two million people die from tuberculosis -- a treatable disease that has been brought under control in the United States, but continues to ravage other parts of the world. This health inequity should prompt a complete rethinking of the way tuberculosis is fought on a global level, argue Salmaan Keshavjee, M.D., Ph.D., and Paul Farmer, M.D., Ph.D., from Brigham and Women's Hospital. Their argument appears in an essay published Sept. 6 in the New England Journal of Medicine.

Contact: Tom Langford
tlangford@partners.org
617-534-1605
Brigham and Women's Hospital

Public Release: 4-Sep-2012
Global health requires new dynamics, suggests science panel
How can science better address global health crises? This week, Rita Colwell, Alice Dautry, Harvey Fineberg, and Kiyoshi Kurokawa discussed priorities and related topics at the 2012 Kavli Prize Science Forum, moderated by BBC's Pallab Ghosh.

Contact: James Cohen
cohen@kavlifoundation.org
The Kavli Foundation

Public Release: 4-Sep-2012
Mobilization: An International Journal
Deadly witch hunts targeted by grassroots women's groups
Witch hunts are common and sometimes deadly in the tea plantations of Jalpaiguri, India. But a surprising source -- small groups of women who meet through a government loan program -- has achieved some success in preventing the longstanding practice, a Michigan State University sociologist found.

Contact: Andy Henion
henion@msu.edu
517-355-3294
Michigan State University

Showing releases 676-700 out of 890.

<< < 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 > >>